{"id":"sulbactam-sodium-ampicillin-sodium","safety":{"commonSideEffects":[{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Rash"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":{"chemblId":"CHEMBL1200758","moleculeType":"Small molecule","molecularWeight":"371.39"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Ampicillin is a beta-lactam antibiotic that binds to penicillin-binding proteins and disrupts bacterial cell wall synthesis. Sulbactam is a beta-lactamase inhibitor that protects ampicillin from degradation by bacterial beta-lactamases, extending the spectrum of activity to include beta-lactamase-producing gram-positive and gram-negative bacteria.","oneSentence":"Sulbactam inhibits bacterial beta-lactamases while ampicillin inhibits bacterial cell wall synthesis, together providing broad-spectrum bactericidal activity against beta-lactamase-producing organisms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:41.386Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections caused by beta-lactamase-producing organisms (skin and soft tissue infections, intra-abdominal infections, gynecological infections)"}]},"trialDetails":[{"nctId":"NCT01888822","phase":"PHASE4","title":"Antibiotic Prophylaxis in Laparoscopic Cholecystectomy","status":"TERMINATED","sponsor":"University of Roma La Sapienza","startDate":"2013-06","conditions":"Cholelithiasis","enrollment":138},{"nctId":"NCT01760109","phase":"PHASE4","title":"Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection","status":"COMPLETED","sponsor":"Xiangbei Welman Pharmaceutical Co., Ltd","startDate":"2011-07","conditions":"Respiratory Tract Infections, Urinary Tract Infections","enrollment":2000},{"nctId":"NCT01793688","phase":"","title":"Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-03-12","conditions":"Pneumonia, Lung Abscess, Peritonitis","enrollment":982},{"nctId":"NCT01118403","phase":"PHASE4","title":"Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological Patients","status":"WITHDRAWN","sponsor":"Hospital Pablo Tobón Uribe","startDate":"2011-03","conditions":"Ventilator Associated Pneumonia","enrollment":""},{"nctId":"NCT01189487","phase":"PHASE3","title":"The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-10","conditions":"Pneumonia, Bacterial","enrollment":47}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["UNASYN-S"],"phase":"phase_3","status":"active","brandName":"Sulbactam Sodium/Ampicillin Sodium","genericName":"Sulbactam Sodium/Ampicillin Sodium","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sulbactam inhibits bacterial beta-lactamases while ampicillin inhibits bacterial cell wall synthesis, together providing broad-spectrum bactericidal activity against beta-lactamase-producing organisms. Used for Bacterial infections caused by beta-lactamase-producing organisms (skin and soft tissue infections, intra-abdominal infections, gynecological infections).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}